Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 938   Home Print this page  Email this page Small font size Default font size Increase font size


 
Table of Contents
ORIGINAL ARTICLE
Year : 2021  |  Volume : 13  |  Issue : 1  |  Page : 47-52  

Is preoperative neutrophil-to-lymphocyte ratio a red flag which can predict high-risk pathological characteristics in renal cell carcinoma?


1 Department of Urology, Kasturba Medical College Hospital, Mangalore, Karnataka, India
2 Department of Biochemistry, Kasturba Medical College Hospital, Mangalore, Karnataka, India

Date of Submission05-Mar-2019
Date of Acceptance28-Jan-2020
Date of Web Publication19-Jan-2021

Correspondence Address:
Dr. Rajesh Kumar Reddy Adapala
Department of Urology, Kasturba Medical College Hospitals, Ambedkar Circle, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka
India
Login to access the Email id


DOI: 10.4103/UA.UA_34_19

Rights and Permissions
   Abstract 


Introduction: Renal cell carcinoma (RCC) is known to invoke both immunological and inflammatory responses. While the neutrophils mediate the tumor-induced inflammatory response, the lymphocytes bring about the various immunological events associated with it. The neutrophil-to-lymphocyte ratio (NLR) is a simple indicator of this dual response. We investigated the association between preoperative NLR and histopathological prognostic variables of RCC intending to find out whether it can be of value as a red flag capable of alerting the clinician as to the biological character of the tumor under consideration.
Methods: Preoperative NLR and clinicopathological variables, namely histological subtype, nuclear grade, staging, lymphovascular invasion, capsular invasion, tumor necrosis, renal sinus invasion, and sarcomatoid differentiation of 60 patients who underwent radical or partial nephrectomy, were analyzed to detect the association between the two.
Results: We found that mean preoperative NLR was significantly higher in clear-cell carcinomas (3.25 ± 0.29) when compared with nonclear-cell carcinomas (2.25 ± 0.63). There was a linear trend of NLR rise as the stage of the disease advanced. A significant rise in preoperative NLR was noted in tumors with various high-risk histopathological features such as tumor size, capsular invasion, tumor necrosis, and sarcomatoid differentiation.
Conclusion: Preoperative measurement of NLR is a simple test which may provide an early clue of high-risk pathological features of renal cell cancer.

Keywords: Clear-cell carcinoma, neutrophil-lymphocyte ratio, radical/partial nephrectomy, renal cell carcinoma


How to cite this article:
Adapala RK, Prabhu G G, Sanman K N, Yalla DR, Shetty R, Venugopal P. Is preoperative neutrophil-to-lymphocyte ratio a red flag which can predict high-risk pathological characteristics in renal cell carcinoma?. Urol Ann 2021;13:47-52

How to cite this URL:
Adapala RK, Prabhu G G, Sanman K N, Yalla DR, Shetty R, Venugopal P. Is preoperative neutrophil-to-lymphocyte ratio a red flag which can predict high-risk pathological characteristics in renal cell carcinoma?. Urol Ann [serial online] 2021 [cited 2021 Feb 28];13:47-52. Available from: https://www.urologyannals.com/text.asp?2021/13/1/47/307382




   Introduction Top


Renal cell carcinoma (RCC) accounts for 3% of all adult cancers in India and 85% of all kidney tumors.[1] Its incidence is increasing significantly in India as well as globally.[2] Up to 30% of patients present with the involvement of lymph nodes or metastatic disease at the initial diagnosis.[3] Its prevalence is more in men and occurs predominantly in the sixth to eighth decade of life.[4],[5]

The relationship between cancer and inflammation was proposed initially by Virchow in 1863, and subsequent studies have established this association.[6],[7] Patients with malignancy exhibit local and systemic inflammatory responses. These could be in the form of infiltration of the tumor by inflammatory cells or measurable parameters, namely acute-phase proteins such as C-reactive protein and albumin, erythrocyte sedimentation rate, and peripheral blood cell counts (neutrophils, lymphocytes, and platelets).[7],[8],[9] The elevated inflammatory markers portend diminished quality of life in patients with advanced malignancy.[8]

Neutrophils preside over ongoing inflammation in the host harboring the malignancy by releasing cytokines and various inflammatory mediators, while the lymphocytes represent a regulatory immune pathway against the tumor. Neutrophil-to-lymphocyte ratio (NLR) integrates information of these two distinct biological response pathways.[10],[11] Raised preoperative NLR was found to be associated with inferior outcomes in various malignancies such as those of the stomach, colon, and the rectum.[12],[13]

Based on the observation of extensive immune cell infiltration of the tumor as well as its responsiveness to immunotherapeutic modalities, RCC has been classified as an“immunogenic” tumor.[14] The role of preoperative NLR in prognostication of RCC was demonstrated in various studies; however, the results of a few are conflicting.[15],[16] The current study aimed to assess the potential role of preoperative NLR in predicting high-risk pathological characteristics of RCC in preoperative setting.


   Methods Top


Study population and data collection

This was a retrospective study in which clinicopathological particulars of 60 patients who underwent radical/partial nephrectomy for RCC from January 2016 to December 2018 at our hospital were extracted from the database and analyzed. The clinical variables included were age, gender, absolute neutrophil count, and absolute lymphocyte count. Preoperative NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. Pathological parameters such as histological subtype, nuclear grade, staging, lymphovascular invasion, capsular invasion, tumor necrosis, renal sinus involvement, and sarcomatoid differentiation were recorded. Those with inadequately documented data, benign renal tumor, and malignancies other than RCCs were excluded from the study. The relationship between preoperative NLR and various pathological parameters was analyzed. Preoperative NLR was also correlated with the size of the renal mass (large versus small renal mass). Small renal mass was defined as the tumor size less than 4cm in maximal diameter.[17] Nuclear grading by using the Fuhrman grading system is validated and accepted to be more reliable in clear-cell subtype of RCCs.[18] Hence, we analyzed the relationship between preoperative NLR and nuclear grading only in clear-cell carcinomas. Further correlation of NLR with overall as well as cancer-free survival of the same cohort is being assessed at present. The results of the second part shall be reported on the completion of the study.

Statistical analysis

The data was analysed using the Statistical Package for the Social Sciences (SPSS) version 20.0 (IBM, Armonk, New York, USA). Normally distributed variables were compared across the groups and a grade using one-way ANOVA followed by post hoc Tukey's multiple comparison test. Two group comparisons were done by students' independent t-test and Mann–Whitney U-test. Categorical variables were analyzed by Chi-square and correlation was performed by Spearman's test. All the results were expressed as mean ± standard deviation/standard error of the mean, and P < 0.05 was considered to be significant.


   Results Top


From the 84 patients who underwent radical/partial nephrectomy during the study period, 60 cases (n = 60) were considered for the analysis after exclusion. The mean age of the study population was 57 ± 13 years. Forty-nine (82%) were male and 11 (18%) were female. The mean preoperative NLR was 3.1 ± 0.26. Majority of the RCCs were clear-cell carcinomas (n = 51, 85%). Other subtypes (n = 9, 15%) were papillary type 1 (n = 2), papillary type 2 (n = 4), chromophobe (n = 1), and multilocular cystic clear-cell carcinoma (n = 2) [Table 1].
Table 1: Clinicopathological characteristics of the study participants (n=60)

Click here to view


A linear trend of NLR rise was observed with advancing stage of the disease [Figure 1]. Significant elevation of preoperative NLR was noted in clear-cell carcinoma (3.25 ± 0.29) when compared with nonclear-cell carcinomas (2.25 ± 0.63) [Figure 2]. Preoperative NLR was raised in high-grade tumors (3.06 ± 0.34) compared to low-grade tumors (2.86 ± 0.5); however, it was statistically insignificant. When the size was taken into consideration, Spearman's correlation test showed a significant positive (r = 0.349, P < 0.01) correlation between preoperative NLR and size of the tumor (small renal mass: 2.63 ± 0.47 versus large renal mass: 3.3 ± 0.32) [Table 2] and [Graph 1]. Other pathological variables of great prognostic significance in which preoperative NLR was significantly elevated were a capsular invasion, tumor necrosis, and sarcomatoid differentiation. An insignificant elevation of NLR was observed in patients with lymphovascular invasion and renal sinus involvement by the tumor [Table 2] and [Figure 2].
Figure 1: Preoperative neutrophil-lymphocyte ratio trend in various pathological stages

Click here to view
Figure 2: Preoperative neutrophil-lymphocyte ratio in various pathological prognostic features (presence vs. absence)

Click here to view
Table 2: Variation in preoperative neutrophil-to-lymphocyte ratio across various clinicopathological categories

Click here to view




   Discussion Top


The etiopathogenesis of cancer is classically described as the interplay between nature and nurture implying both inheritance and environment play important roles in tumorigenesis.[19] Of the two, the environmental factors have been observed to induce some form of chronic inflammation.[20] Besides tumorigenesis, the inflammatory milieu also aids in the proliferation and survival of malignant cells, subverts adaptive immune responses, and promotes angiogenesis and metastasis.[21]

Neutrophils play a crucial role in inflammation-driven tumorigenesis. This was well-documented when neutrophils were shown to directly promote carcinogenesis in a mouse model of colitis.[22] Tumor-associated neutrophils were also shown to support angiogenesis through the secretion of proangiogenic factors and promote tumor cell dissemination through metalloproteinases which can modify the extracellular membrane.[23],[24] On the other hand, there is increasing evidence supporting the role of lymphocytes in immune responses against cancer.[25],[26] Therefore, a low lymphocyte count may be indicative of an inadequate immunologic reaction to the tumor, and consequently, a defence cancer, resulting in a poor prognosis.[9],[27] These two major cell lines are expressed as NLR which represents the dual phenomena invoked by tumors.[28]

Previous studies have shown that preoperative NLR provides independent prognostic information of the patients with various malignancies including RCC.[12],[13],[29] Tumor staging and various histological features such as tumor grade, histological subtype, lymphovascular invasion, and tumor necrosis provide strong clues to prognosticate the natural course of RCC.[29] While NLR can be measured preoperatively, the study of pathological characteristics depends on the availability of biopsy or surgical specimen of the tumor. Hence, the relationship between these two prognostic variables carries a prognostic potential as to the biological characteristics of a given tumor. We analyzed the possible association of NLR and the above-mentioned pathological prognostic factors to determine this predictive potential of NLR in anticipating adverse tumor characteristics preoperatively.

We observed a linear rise in the preoperative NLR with ascending stages of the tumor [Figure 1]. However, we did not find a statistically significant rise in preoperative NLR in high-grade tumors when compared to low-grade tumors. The conflicting relationship between preoperative NLR and grading has been made out in other studies too. Otunctemur et al.[30] compared the relationship of preoperative NLR with the renal tumor stage and grade. They found that preoperative NLR rise was statistically significant in the higher T-stage and grade. However, Arda et al.[31] found no difference in preoperative NLR in different Fuhrman-graded cases.

Further, preoperative NLR was found to correlate significantly with the tumor size [Graph 1]. Preoperative NLR was low in small renal masses. Arda et al.[31] observed a similar linear relationship between the tumor size and the NLR in nonmetastatic RCC. When pathological subtype was taken into consideration, we found a significant elevation of preoperative NLR in clear-cell carcinoma. It is well known that clear-cell carcinoma carries a worse prognosis than other subtypes of RCC even after stratification for stage and grade.[32]

We also compared the preoperative NLR with other histopathological prognostic factors in which significant elevation was observed in patients with tumor necrosis, capsular invasion, and sarcomatoid differentiation [Figure 2]. However, preoperative NLR rise was found to be insignificant in cases of lymphovascular invasion and renal sinus involvement. In a large, multicenter cohort analysis conducted by Byun et al.,[16] a significant preoperative NLR elevation was observed only in cases of tumor necrosis and sarcomatoid differentiation among the histopathological characteristics studied. Similar to this, Gu et al.[33] found that preoperative NLR serves as a potential prognostic biomarker in patients with sarcomatoid RCC.

Even though there are many studies in the literature which have proven the prognostic value of preoperative NLR in terms of predicting the outcome, the relationship with various pathological prognostic factors in RCC exclusively has not been studied in detail.[16],[34] Our study is unique in this regard. From the observations of the current study, it appears that an elevated preoperative NLR is a red flag alerting the clinician as well as a pathologist of probable tumor aggressiveness. It has a potential utility as a caution to care provider to look for clinical as well as radiological signs of invasion preoperatively and also check for intraoperative evidence of subtle infiltration and nodal involvement.

NLR can be affected by systemic inflammatory conditions, but its association with various high risk pathological prognostic factors of RCC sets it apart as a parameter worth measuring.[13] Hence, there is a need for an integrated scoring system/nomogram which uses a combination of various inflammatory prognostic markers or tumor-specific inflammatory marker to improve the specificity. Intra- and interobserver discrepancies among pathologists while diagnosing various tumor attributes can affect the validity of the relationship of NLR with various tumor characteristics. This is true in the case of Furman grading.[35] A histopathological study by a single uropathologist might decrease such discrepancies. In spite of these limitations, the association of elevated preoperative NLR with aggressive tumor characteristics suggests that this parameter has utility in preempting a biologically virulent tumor. Further correlation of NLR with overall as well as cancer-free survival of the same cohort is being studied. The results of the subsequent analysis might throw light on precise prognostication.


   Conclusion Top


In patients with RCC, we found a significant elevation of preoperative NLR with various pathological variables which carry prognostic significance, namely clear-cell subtype, higher stage, larger tumor size, renal capsular invasion, and sarcomatoid differentiation. Preoperative measurement of NLR is a simple test to employ, and when high, the care provider should anticipate high-risk pathological characteristics of RCC. Besides the prognostic utility, our study also strengthens the link between RCC and inflammation.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Yuvaraja TB, Waigankar S, Bakshi G, Prakash G. Genitourinary cancers: Summary of Indian data. South Asian J Cancer 2016;5:122-4.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Katoch VM, Nandkumar A. Time Trends in Cancer Incidence Rates 1982-2010. ICMR Publication; July, 2013. Available from: http://www. ncrpindia.org. [Last accessed on 2016 Aug 12].  Back to cited text no. 2
    
3.
American Cancer Society Report. Available from: http://www.healthline.com/health/rcc/stage-4-renal-cell-carcinoma. [Last accessed on 2016 Aug 12].  Back to cited text no. 3
    
4.
Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol 2011;60:615-21.  Back to cited text no. 4
    
5.
Rampersaud EN, Klatte T, Bass G, Patard JJ, Bensaleh K, Böhm M, et al. The effect of gender and age on kidney cancer survival: Younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol 2014;32:30.e9-13.  Back to cited text no. 5
    
6.
Balkwill F, Mantovani A. Inflammation and cancer: Back to virchow? Lancet 2001;357:539-45.  Back to cited text no. 6
    
7.
Qayyum T, McArdle PA, Lamb GW, Going JJ, Orange C, Seywright M, et al. Prospective study of the role of inflammation in renal cancer. Urol Int 2012;88:277-81.  Back to cited text no. 7
    
8.
Torjesen I. Raised inflammatory markers may indicate poorer quality of life in advanced cancer. BMJ 2016;353:i3582.  Back to cited text no. 8
    
9.
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014;23:1204-12.  Back to cited text no. 9
    
10.
Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.  Back to cited text no. 10
    
11.
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218-30.  Back to cited text no. 11
    
12.
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-4.  Back to cited text no. 12
    
13.
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215-20.  Back to cited text no. 13
    
14.
Itsumi M, Tatsugami K. Immunotherapy for renal cell carcinoma. Clin Dev Immunol. 2010;2010:284581.   Back to cited text no. 14
    
15.
Bazzi WM, Dejbakhsh SZ, Bernstein M, Russo P. Neutrophil-lymphocyte ratio in small renal masses. ISRN Urol. 2014;2014:759253.  Back to cited text no. 15
    
16.
Byun SS, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, et al. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in nonmetastatic renal cell carcinoma: A large, multicenter cohort analysis. Biomed Res Int 2016;2016: https://doi.org/10.1155/2016/5634148.  Back to cited text no. 16
    
17.
Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N Engl J Med 2010;362:624-34.  Back to cited text no. 17
    
18.
Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 2009;22 Suppl 2:S24-36.  Back to cited text no. 18
    
19.
Hyndman IJ. Review: The contribution of both nature and nurture to carcinogenesis and progression in solid tumours. Cancer Microenviron 2016;9:63-9.  Back to cited text no. 19
    
20.
Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: Short-term friend, long-term foe. Clin Cancer Res 2009;15:425-30.  Back to cited text no. 20
    
21.
Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb) 2011;21:264-75.  Back to cited text no. 21
    
22.
Shang K, Bai YP, Wang C, Wang Z, Gu HY, Du X, et al. Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One 2012;7:e51848.  Back to cited text no. 22
    
23.
Tazzyman S, Lewis CE, Murdoch C. Neutrophils: Key mediators of tumour angiogenesis. Int J Exp Pathol 2009;90:222-31.  Back to cited text no. 23
    
24.
Granot Z, Jablonska J. Distinct Functions of Neutrophil in Cancer and Its Regulation. Mediators Inflamm 2015;2015:701067.  Back to cited text no. 24
    
25.
Yo-Ping L, Chung-Jiuan J, Shu-Ching C. The Roles of CD4+ T Cells in Tumor Immunity. ISRN Immunol 2011; https://doi.org/10.5402/2011/497397.  Back to cited text no. 25
    
26.
Tsou P, Katayama H, Ostrin EJ, Hanash SM. The emerging role of B cells in tumor immunity. Cancer Res 2016;76:5597-601.  Back to cited text no. 26
    
27.
Müller-Hübenthal B, Azemar M, Lorenzen D, Huber M, Freudenberg MA, Galanos C, et al. Tumour biology: Tumour-associated inflammation versus antitumor immunity. Anticancer Res 2009;29:4795-805.  Back to cited text no. 27
    
28.
Tsujino T, Komura K, Ichihashi A, Tsutsumi T, Matsunaga T, Yoshikawa Y, et al. The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma. Oncotarget 2017;8:110311-25.  Back to cited text no. 28
    
29.
Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, et al. Prognostic factors and predictive models in renal cell carcinoma: A contemporary review. Eur Urol 2011;60:644-61.  Back to cited text no. 29
    
30.
Otunctemur A, Dursun M, Besiroglu H, Ozer K, Horsanali O, Ozbek E. Clinical significance of preoperative neutrophil-to-lymphocyte ratio in renal cell carcinoma. Int Braz J Urol 2016;42:678-84.  Back to cited text no. 30
    
31.
Arda E, Yuksel I, Cakiroglu B, Akdeniz E, Cilesiz N. Valuation of neutrophil/lymphocyte ratio in renal cell carcinoma grading and progression. Cureus 2018;10:e2051.  Back to cited text no. 31
    
32.
Deng FM, Melamed J. Histologic variants of renal cell carcinoma: Does tumor type influence outcome? Urol Clin North Am 2012;39:119-32, v.  Back to cited text no. 32
    
33.
Gu L, Ma X, Li H, Chen L, Xie Y, Zhao C, et al. Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram. Sci Rep 2016;6:23846.  Back to cited text no. 33
    
34.
Keskin S, Keskin Z, Taskapu HH, Kalkan H, Kaynar M, Poyraz N, et al. Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma. BMC Urol 2014;14:95.  Back to cited text no. 34
    
35.
Bektas S, Bahadir B, Kandemir NO, Barut F, Gul AE, Ozdamar SO. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma. Kaohsiung J Med Sci 2009;25:596-600.  Back to cited text no. 35
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Methods
   Results
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed162    
    Printed2    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal